• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大血管血管炎放射学损伤评估评分系统的开发(联合动脉炎损伤评分,CARDS)。

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS).

作者信息

Nakagomi Daiki, Cousins Claire, Sznajd Jan, Furuta Shunsuke, Mohammad Aladdin J, Luqmani Raashid, Jayne David

机构信息

Lupus and Vasculitis Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.

Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.

出版信息

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):139-145. Epub 2017 Mar 13.

PMID:28339357
Abstract

OBJECTIVES

Outcome assessment in large-vessel vasculitis (LVV) remains challenging and this impairs patient management and the conduct of clinical studies. Previous proposals for outcome tools have not included imaging. This study aimed to develop an imaging score to quantify damage in LVV and to assess the difference between Takayasu (TAK) and giant cell arteritis (GCA).

METHODS

Ninety-six patients (41 TAK, 55 GCA) were identified from local registries at two University Hospitals in the UK. Radiologic lesions including stenosis, occlusion and aneurysm were evaluated in 25 arterial regions by enhanced computed tomography or magnetic resonance angiography. Lesion correlation with combined damage assessment scores was employed in a multiple regression analysis to define the weight of individual lesions and develop a damage index.

RESULTS

A numerical damage index was developed: the "Combined Arteritis Damage Score (CARDS)". The index was derived from a formula: number of regions with mild stenosis × 0.6 + number of regions with moderate to severe stenosis × 1.2 + number with occlusions × 1.6 + number with aneurysms × 0.8 in 25 arterial regions. The median CARDS was higher in TAK than GCA (4.1 and 0.6, interquartile range 1.3-5.7 and 0-3, p<0.001).

CONCLUSIONS

We have developed a damage assessment tool, CARDS, based on imaging in LVV of potential value to clinical studies and patient management. TAK and GCA differ in the radiologic severity of disease.

摘要

目的

大血管血管炎(LVV)的疗效评估仍然具有挑战性,这会影响患者管理和临床研究的开展。以往关于疗效评估工具的提议未纳入影像学检查。本研究旨在开发一种影像学评分系统,以量化LVV中的损伤情况,并评估高安动脉炎(TAK)和巨细胞动脉炎(GCA)之间的差异。

方法

从英国两家大学医院的本地登记处识别出96例患者(41例TAK,55例GCA)。通过增强计算机断层扫描或磁共振血管造影对25个动脉区域的放射学病变(包括狭窄、闭塞和动脉瘤)进行评估。在多元回归分析中采用病变与综合损伤评估评分的相关性来确定各个病变的权重,并制定损伤指数。

结果

开发了一个数值损伤指数:“联合动脉炎损伤评分(CARDS)”。该指数由一个公式得出:25个动脉区域中轻度狭窄区域数×0.6 + 中度至重度狭窄区域数×1.2 + 闭塞区域数×1.6 + 动脉瘤区域数×0.8。TAK患者的CARDS中位数高于GCA患者(分别为4.1和0.6,四分位间距为1.3 - 5.7和0 - 3,p<0.001)。

结论

我们基于LVV的影像学检查开发了一种具有潜在临床研究和患者管理价值的损伤评估工具CARDS。TAK和GCA在疾病的放射学严重程度方面存在差异。

相似文献

1
Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS).大血管血管炎放射学损伤评估评分系统的开发(联合动脉炎损伤评分,CARDS)。
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):139-145. Epub 2017 Mar 13.
2
Novel Angiographic Scores for evaluation of Large Vessel Vasculitis.新型大血管血管炎影像学评分。
Sci Rep. 2018 Oct 29;8(1):15979. doi: 10.1038/s41598-018-34395-7.
3
Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?大血管血管炎的临床特征和影像学表现:高安动脉炎和巨细胞动脉炎是两种不同的疾病还是同一实体?
J Rheumatol. 2015 Feb;42(2):300-8. doi: 10.3899/jrheum.140562. Epub 2014 Nov 15.
4
Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.与巨细胞动脉炎相比,Takayasu 动脉炎的临床症状及相关血管影像学表现。
Ann Rheum Dis. 2020 Feb;79(2):262-267. doi: 10.1136/annrheumdis-2019-216145. Epub 2019 Oct 24.
5
Ultrasound imaging in the diagnosis of large vessel vasculitis.超声成像在大血管血管炎诊断中的应用
Vasa. 2017 Jul;46(4):241-253. doi: 10.1024/0301-1526/a000625. Epub 2017 Mar 23.
6
Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?颅外巨细胞动脉炎和高安动脉炎:它们有多相似?
Semin Arthritis Rheum. 2015 Jun;44(6):724-8. doi: 10.1016/j.semarthrit.2015.01.005. Epub 2015 Jan 23.
7
Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis.大血管血管炎的血管体格检查结果与血管造影病变的相关性。
J Rheumatol. 2012 Feb;39(2):303-9. doi: 10.3899/jrheum.110652. Epub 2011 Dec 15.
8
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.意大利人群中的 Takayasu 动脉炎和大动脉巨细胞动脉炎。来自单个机构队列的 184 例综合分析。
Semin Arthritis Rheum. 2023 Apr;59:152173. doi: 10.1016/j.semarthrit.2023.152173. Epub 2023 Feb 8.
9
Comparison of magnetic resonance angiography and F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis.磁共振血管造影与 F-氟代脱氧葡萄糖正电子发射断层扫描在大血管血管炎中的比较。
Ann Rheum Dis. 2018 Aug;77(8):1165-1171. doi: 10.1136/annrheumdis-2018-213102. Epub 2018 Apr 17.
10
Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia.大血管血管炎患者与高脂血症患者的血管钙化比较。
Semin Arthritis Rheum. 2019 Jun;48(6):1068-1073. doi: 10.1016/j.semarthrit.2018.09.001. Epub 2018 Sep 17.

引用本文的文献

1
Comparison and Significance of Contrast-Enhanced Computed Tomographic Findings of Large-Vessel Vasculitis Before and After Treatment: Differences Between Takayasu Arteritis and Giant Cell Arteritis.治疗前后大血管血管炎的对比增强计算机断层扫描结果的比较及意义:高安动脉炎与巨细胞动脉炎的差异
Eur J Rheumatol. 2024 Oct 14;11(3):371-377. doi: 10.5152/eurjrheum.2024.24056.
2
F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis.F-FDG-PET/MR 成像用于监测大血管血管炎的疾病活动。
Nat Commun. 2024 Aug 25;15(1):7314. doi: 10.1038/s41467-024-51613-1.
3
Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis.
大动脉炎疾病评估的结局指标和生物标志物
Diagnostics (Basel). 2022 Oct 21;12(10):2565. doi: 10.3390/diagnostics12102565.
4
Large-vessel vasculitis.大血管血管炎
Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5.
5
Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.增强肝纤维化评分作为大动脉炎患者血管损伤评估的生物标志物——一项初步研究
J Cardiovasc Dev Dis. 2021 Dec 14;8(12):187. doi: 10.3390/jcdd8120187.
6
Vascular imaging of patients with refractory Takayasu arteritis treated with tocilizumab: post hoc analysis of a randomized controlled trial.托珠单抗治疗难治性多发性大动脉炎患者的血管成像:一项随机对照试验的事后分析。
Rheumatology (Oxford). 2022 May 30;61(6):2360-2368. doi: 10.1093/rheumatology/keab684.
7
Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis.用于诊断和随访 Takayasu 动脉炎患者的影像学方式。
Turk J Med Sci. 2021 Feb 26;51(1):224-230. doi: 10.3906/sag-2005-70.
8
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides.大血管血管炎的诊断、监测和预后预测的影像学检查。
Curr Rheumatol Rep. 2020 Sep 21;22(11):76. doi: 10.1007/s11926-020-00955-y.
9
Mechanism and biomarkers in aortitis--a review.巨细胞动脉炎的发病机制和生物标志物——综述。
J Mol Med (Berl). 2020 Jan;98(1):11-23. doi: 10.1007/s00109-019-01838-1. Epub 2019 Oct 30.
10
The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis.血管成像在推进大血管血管炎临床护理与研究中的作用
Curr Treatm Opt Rheumatol. 2019 Mar;5(1):20-35. doi: 10.1007/s40674-019-00114-0. Epub 2019 Feb 9.